Immunologic response to recombinant hirudin in HIT type II patients during long-term treatment

We prospectively investigated 27 patients with heparin-induced thrombocytopenia (HIT) type II who were subsequently treated with r-hirudin. Patients with venous or arterial thromboembolism were treated with activated partial thromboplastin time (aPTT)-controlled intravenous r-hirudin (n = 19; mean 1...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Huhle, Günter (VerfasserIn) , Hoffmann, Ursula (VerfasserIn) , Song, Xuehong (VerfasserIn) , Wang, Lianchun (VerfasserIn) , Heene, Dieter L. (VerfasserIn) , Harenberg, Job (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 1999
In: British journal of haematology
Year: 1999, Jahrgang: 106, Heft: 1, Pages: 195-201
ISSN:1365-2141
DOI:10.1046/j.1365-2141.1999.01532.x
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1046/j.1365-2141.1999.01532.x
Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1046/j.1365-2141.1999.01532.x
Volltext
Verfasserangaben:Huhle, Hoffmann, Song, Wang, Heene, Harenberg

MARC

LEADER 00000caa a2200000 c 4500
001 1801054975
003 DE-627
005 20220820175102.0
007 cr uuu---uuuuu
008 220505s1999 xx |||||o 00| ||eng c
024 7 |a 10.1046/j.1365-2141.1999.01532.x  |2 doi 
035 |a (DE-627)1801054975 
035 |a (DE-599)KXP1801054975 
035 |a (OCoLC)1341459682 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Huhle, Günter  |e VerfasserIn  |0 (DE-588)1077938500  |0 (DE-627)837763940  |0 (DE-576)173334431  |4 aut 
245 1 0 |a Immunologic response to recombinant hirudin in HIT type II patients during long-term treatment  |c Huhle, Hoffmann, Song, Wang, Heene, Harenberg 
264 1 |c 1999 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Elektronische Reproduktion der Druck-Ausgabe 25 Dezember 2001 
500 |a Gesehen am 05.05.2022 
520 |a We prospectively investigated 27 patients with heparin-induced thrombocytopenia (HIT) type II who were subsequently treated with r-hirudin. Patients with venous or arterial thromboembolism were treated with activated partial thromboplastin time (aPTT)-controlled intravenous r-hirudin (n = 19; mean 19.3 d) followed by subcutaneous r-hirudin (n = 6; mean 22.5 d) and oral anticoagulation. Patients without thromboembolism were treated with subcutaneous r-hirudin (n = 8; mean 25.9 d). Four patients were readmitted to subcutaneous r-hirudin for a mean duration of 32 d. The incidence of r-hirudin antibodies was 84% for intravenously treated patients and 50% in subcutaneously treated patients. The patients (n = 27) showed a 74% overall incidence of r-hirudin antibodies, mainly of the IgG-subclass, without seroconversion before day 6 and after day 32 of r-hirudin treatment or during r-hirudin treatment. None of the patients showed onset or recurrence of venous or arterial thromboembolism, systemic allergic reactions or IgE-antibody development. During intravenous and subcutaneous administration of r-hirudin the aPTT and the ecarin clotting time was increased in the antibody-positive patients compared to antibody-negative patients. Therefore we assume that r-hirudin antibodies may reduce r-hirudin metabolism. 
650 4 |a allergy 
650 4 |a antibodies 
650 4 |a heparin-induced thrombocytopenia 
650 4 |a recombinant hirudin 
700 1 |a Hoffmann, Ursula  |d 1962-  |e VerfasserIn  |0 (DE-588)115587098  |0 (DE-627)691432406  |0 (DE-576)289964113  |4 aut 
700 1 |a Song, Xuehong  |d 1966-  |e VerfasserIn  |0 (DE-588)122397908  |0 (DE-627)705893464  |0 (DE-576)293252955  |4 aut 
700 1 |a Wang, Lianchun  |d 1968-  |e VerfasserIn  |0 (DE-588)120909707  |0 (DE-627)705082946  |0 (DE-576)292442653  |4 aut 
700 1 |a Heene, Dieter L.  |d 1935-  |e VerfasserIn  |0 (DE-588)1103551418  |0 (DE-627)861344979  |0 (DE-576)470661275  |4 aut 
700 1 |a Harenberg, Job  |d 1950-  |e VerfasserIn  |0 (DE-588)108825507  |0 (DE-627)655891498  |0 (DE-576)339563745  |4 aut 
773 0 8 |i Enthalten in  |t British journal of haematology  |d Oxford [u.a.] : Wiley-Blackwell, 1955  |g 106(1999), 1, Seite 195-201  |h Online-Ressource  |w (DE-627)269758941  |w (DE-600)1475751-5  |w (DE-576)09113997X  |x 1365-2141  |7 nnas  |a Immunologic response to recombinant hirudin in HIT type II patients during long-term treatment 
773 1 8 |g volume:106  |g year:1999  |g number:1  |g pages:195-201  |g extent:7  |a Immunologic response to recombinant hirudin in HIT type II patients during long-term treatment 
856 4 0 |u https://doi.org/10.1046/j.1365-2141.1999.01532.x  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1046/j.1365-2141.1999.01532.x  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220505 
994 |a 1999 
998 |g 108825507  |a Harenberg, Job  |m 108825507:Harenberg, Job  |d 60000  |d 61000  |d 60000  |e 60000PH108825507  |e 61000PH108825507  |e 60000PH108825507  |k 0/60000/  |k 1/60000/61000/  |k 0/60000/  |p 6  |y j 
998 |g 1103551418  |a Heene, Dieter L.  |m 1103551418:Heene, Dieter L.  |d 60000  |d 61000  |d 60000  |e 60000PH1103551418  |e 61000PH1103551418  |e 60000PH1103551418  |k 0/60000/  |k 1/60000/61000/  |k 0/60000/  |p 5 
998 |g 120909707  |a Wang, Lianchun  |m 120909707:Wang, Lianchun  |d 60000  |d 61000  |e 60000PW120909707  |e 61000PW120909707  |k 0/60000/  |k 1/60000/61000/  |p 4 
998 |g 122397908  |a Song, Xuehong  |m 122397908:Song, Xuehong  |d 60000  |d 61000  |e 60000PS122397908  |e 61000PS122397908  |k 0/60000/  |k 1/60000/61000/  |p 3 
998 |g 115587098  |a Hoffmann, Ursula  |m 115587098:Hoffmann, Ursula  |d 60000  |d 61000  |d 60000  |e 60000PH115587098  |e 61000PH115587098  |e 60000PH115587098  |k 0/60000/  |k 1/60000/61000/  |k 0/60000/  |p 2 
998 |g 1077938500  |a Huhle, Günter  |m 1077938500:Huhle, Günter  |d 60000  |d 61000  |e 60000PH1077938500  |e 61000PH1077938500  |k 0/60000/  |k 1/60000/61000/  |p 1  |x j 
999 |a KXP-PPN1801054975  |e 4129764608 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Elektronische Reproduktion der Druck-Ausgabe 25 Dezember 2001","Gesehen am 05.05.2022"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"recId":"1801054975","person":[{"given":"Günter","family":"Huhle","role":"aut","roleDisplay":"VerfasserIn","display":"Huhle, Günter"},{"family":"Hoffmann","given":"Ursula","roleDisplay":"VerfasserIn","display":"Hoffmann, Ursula","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Song, Xuehong","role":"aut","family":"Song","given":"Xuehong"},{"family":"Wang","given":"Lianchun","display":"Wang, Lianchun","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Heene, Dieter L.","given":"Dieter L.","family":"Heene"},{"given":"Job","family":"Harenberg","role":"aut","roleDisplay":"VerfasserIn","display":"Harenberg, Job"}],"title":[{"title_sort":"Immunologic response to recombinant hirudin in HIT type II patients during long-term treatment","title":"Immunologic response to recombinant hirudin in HIT type II patients during long-term treatment"}],"physDesc":[{"extent":"7 S."}],"relHost":[{"language":["eng"],"corporate":[{"display":"British Society for Haematology","roleDisplay":"Herausgebendes Organ","role":"isb"},{"role":"isb","roleDisplay":"Herausgebendes Organ","display":"European Hematology Association"}],"recId":"269758941","disp":"Immunologic response to recombinant hirudin in HIT type II patients during long-term treatmentBritish journal of haematology","note":["Gesehen am 08.05.08"],"type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"extent":"7","volume":"106","text":"106(1999), 1, Seite 195-201","issue":"1","pages":"195-201","year":"1999"},"titleAlt":[{"title":"the official journal of the British Society of Haematology"},{"title":"BJH ; the official journal of the British Society for Haematology"}],"pubHistory":["1.1955 -"],"title":[{"subtitle":"BJHaem : an official journal of the British Society for Haematology","title":"British journal of haematology","title_sort":"British journal of haematology"}],"physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["ed. R. B. Thompson [u.a.]"]},"id":{"zdb":["1475751-5"],"eki":["269758941"],"doi":["10.1111/(ISSN)1365-2141"],"issn":["1365-2141"]},"origin":[{"dateIssuedDisp":"1955-","dateIssuedKey":"1955","publisher":"Wiley-Blackwell ; Blackwell Science ; Blackwell","publisherPlace":"Oxford [u.a.] ; Oxford ; Oxford [u.a.]"}]}],"name":{"displayForm":["Huhle, Hoffmann, Song, Wang, Heene, Harenberg"]},"origin":[{"dateIssuedKey":"1999","dateIssuedDisp":"1999"}],"id":{"eki":["1801054975"],"doi":["10.1046/j.1365-2141.1999.01532.x"]}} 
SRT |a HUHLEGUENTIMMUNOLOGI1999